Lapatinib plus capecitabine for HER2-positive advanced breast cancer.
N Engl J Med. 2006 Dec 28;355(26):2733-43. doi: 10.1056/NEJMoa064320.
N Engl J Med. 2006.
PMID: 17192538
Free article.
Clinical Trial.